Nicola Flaum

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Science Medical Science professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (10)

Richard Edmondson

The University of Manchester

UNITED KINGDOM

View details

Emma Crosbie

The University of Manchester

UNITED KINGDOM

View details

Silvia Riva

Associate Professor

St Mary's University

UNITED KINGDOM

View details

Robert Morgan

The University of Manchester

UNITED KINGDOM

View details

John Bowes

The University of Manchester

UNITED KINGDOM

View details

Miriam Smith

Senior Lecturer in Cancer Genomics

The University of Manchester

UNITED KINGDOM

View details

Gareth Evans

The University of Manchester

UNITED KINGDOM

View details

Gordon Jayson

The University of Manchester

UNITED KINGDOM

View details

Natalie Cook

The University of Manchester

UNITED KINGDOM

View details

Emma Woodward

Manchester University NHS Foundation Trust

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicola Flaum

Research Interests

Explore related searches

Contact this professor

Articles (12)

Clinical implementation of polygenic risk scores

High-grade serous ovarian cancer after bilateral salpingo-oophorectomy

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene

Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population

Is reflex germline BRCA1/2 testing necessary in women diagnosed with non-mucinous high-grade epithelial ovarian cancer aged 80 years or older?

MSH2is the very young onset ovarian cancer predisposition gene, notBRCA1

Optimisation of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer

High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer

Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer

Dominant‐negative pathogenic variant BRIP1 c.1045G>C is a high‐risk allele for non‐mucinous epithelial ovarian cancer: A case‐control study

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.

Collaborators (10)

Richard Edmondson

Emma Crosbie

Silvia Riva

Robert Morgan

John Bowes

Miriam Smith

Gareth Evans

Gordon Jayson

Natalie Cook

Emma Woodward

Make your next move.